发明名称 NEW GENE THERAPY AGENT
摘要 <P>PROBLEM TO BE SOLVED: To provide a therapy agent effective for primary tumor of cancer, more precisely, an NK4 gene therapy agent and a recombinant NK4 protein preparation effective for prevention and therapy of the cancer, to provide a therapeutic agent also effective for metastasis of the cancer, more precisely the NK4 gene therapy agent and the recombinant NK4 protein preparation effective for prevention and therapy of the cancer metastasis, and to provide a therapeutic agent effective for disease caused by vascularization including the cancer, more precisely the NK4 gene therapy agent and the recombinant NK4 protein preparation effective for the disease caused by the vascularization. <P>SOLUTION: The DNA containing a base sequence comprising a specific sequence, or the DNA containing a DNA hybridizing with the DNA under a stringent condition is provided. <P>COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009159883(A) 申请公布日期 2009.07.23
申请号 JP20080000501 申请日期 2008.01.07
申请人 KRINGLE PHARMA INC 发明人 NAKAMURA TOSHIICHI
分类号 C12N15/09;A61K9/127;A61K35/76;A61K38/00;A61K45/00;A61K48/00;A61P9/00;A61P35/00;A61P35/04;A61P43/00;C07K14/47;C12N1/19;C12N1/21;C12N5/10;C12P21/02;G01N33/15;G01N33/50 主分类号 C12N15/09
代理机构 代理人
主权项
地址